Clinical Trial Update: Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects [Phase 4]

View source ↗

Summary

Phase 4 study evaluating maraviroc in immunological non-responders among HIV-1-infected subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: ASST Fatebenefratelli Sacco | Conditions: HIV Infections | Phase 4 | Status: COMPLETED